Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

The Factors Affecting Recurrence of Symptoms after Infrainguinal Arterial Endovascular Angioplasty

  • Bae, Mi Ju (Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital) ;
  • Lee, Jong Geun (Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital) ;
  • Chung, Sung Woon (Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital) ;
  • Lee, Chung Won (Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital) ;
  • Kim, Chang Won (Department of Radiology, Pusan National University Hospital)
  • Received : 2014.03.06
  • Accepted : 2014.09.15
  • Published : 2014.12.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: This study reports the result of endovascular treatment for arterial occlusive disease limited to femoropopliteal lesions, focusing on the recurrence of symptoms instead of patency. Methods: This was a retrospective, single-center study. From April 2007 to November 2011, 48 limbs in 38 patients underwent endovascular stenting or balloon angioplasty to treat femoropopliteal arterial occlusive disease. The factors affecting the recurrence of symptoms were analyzed. Results: The mean age of the patients was $69.60{\pm}7.62$ years. Among the baseline characteristics of the patients, initial hyperlipidemia was the most important factor affecting the recurrence of symptoms (relative risk=5.810, p=0.031). The presence of a dorsal arch was also a significant factor (relative risk=0.675, p=0.047). Conclusion: The major factors that affect the recurrence of symptoms after endovascular treatment for femoropopliteal arterial occlusive lesions are hyperlipidemia and the presence of a dorsal arch. Therefore, the usage of lipid-lowering agents after endovascular treatment and taking the presence of a dorsal arch into consideration are important elements of managing the recurrence of symptoms.

Keywords

References

  1. Fogarty TJ, Cranley JJ, Krause RJ, Strasser ES, Hafner CD. A method for extraction of arterial emboli and thrombi. Surg Gynecol Obstet 1963;116:241-4.
  2. Ravin RA, Faries PL. Infrainguinal disease: endovascular treatment. In: Cronenwett JL, Johnston KW, editors. Rutherford's vascular surgery. 8th ed. Philadelphia: Saunders/Elsevier; 2014. p. 1782-800.
  3. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45 Suppl S:S5-67. https://doi.org/10.1016/j.jvs.2006.12.037
  4. Parsons RE, Suggs WD, Lee JJ, Sanchez LA, Lyon RT, Veith FJ. Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting? J Vasc Surg 1998;28:1066-71. https://doi.org/10.1016/S0741-5214(98)70033-3
  5. Treiman GS, Treiman RL, Ichikawa L, Van Allan R. Should percutaneous transluminal angioplasty be recommended for treatment of infrageniculate popliteal artery or tibioperoneal trunk stenosis? J Vasc Surg 1995;22:457-63. https://doi.org/10.1016/S0741-5214(95)70015-3
  6. Kudo T, Chandra FA, Ahn SS. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg 2005;41:423-35. https://doi.org/10.1016/j.jvs.2004.11.041
  7. Cheng SW, Ting AC, Ho P. Angioplasty and primary stenting of high-grade, long-segment superficial femoral artery disease: is it worthwhile? Ann Vasc Surg 2003;17:430-7. https://doi.org/10.1007/s10016-003-0028-8
  8. Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss. J Vasc Surg 2008;48:619-25. https://doi.org/10.1016/j.jvs.2008.04.013
  9. DeRubertis BG, Pierce M, Chaer RA, et al. Lesion severity and treatment complexity are associated with outcome after percutaneous infra-inguinal intervention. J Vasc Surg 2007;46:709-16. https://doi.org/10.1016/j.jvs.2007.05.059
  10. Lee JJ, Katz SG. The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries. J Vasc Surg 2012;55:994-1000. https://doi.org/10.1016/j.jvs.2011.10.106
  11. McDermott MM, Carroll TJ, Kibbe M, et al. Proximal superficial femoral artery occlusion, collateral vessels, and walking performance in peripheral artery disease. JACC Cardiovasc Imaging 2013;6:687-94. https://doi.org/10.1016/j.jcmg.2012.10.024
  12. Ziegler MA, Distasi MR, Bills RG, et al. Marvels, mysteries, and misconceptions of vascular compensation to peripheral artery occlusion. Microcirculation 2010;17:3-20. https://doi.org/10.1111/j.1549-8719.2010.00008.x
  13. Palmer-Kazen U, Wahlberg E. Arteriogenesis in peripheral arterial disease. Endothelium 2003;10:225-32. https://doi.org/10.1080/713715232
  14. Shyy YJ, Hsieh HJ, Usami S, Chien S. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. Proc Natl Acad Sci U S A 1994;91:4678-82. https://doi.org/10.1073/pnas.91.11.4678
  15. Prior BM, Lloyd PG, Ren J, et al. Time course of changes in collateral blood flow and isolated vessel size and gene expression after femoral artery occlusion in rats. Am J Physiol Heart Circ Physiol 2004;287:H2434-47. https://doi.org/10.1152/ajpheart.00398.2004

Cited by

  1. The association between periprocedural factors and the late outcome of percutaneous stenting of lower extremity arteries. A retrospective cohort study vol.11, pp.2, 2014, https://doi.org/10.5114/pwki.2015.52283
  2. Significance of Distal Runoff Score as a Key Influencer on Clinical Outcomes after Endovascular Interventions for Superficial Femoral Artery Disease vol.73, pp.None, 2014, https://doi.org/10.1016/j.avsg.2020.11.024
  3. Role of Vascular Smooth Muscle Cell Phenotype Switching in Arteriogenesis vol.22, pp.19, 2014, https://doi.org/10.3390/ijms221910585